And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Under the circumstances, you may not be surprised to learn our agenda is rather modest. We plan to catch up on our reading, hang with our short person, and promenade with the ever-growing official mascot. And what about you? This is a fine time to enjoy the great outdoors. You could boost the economy by supporting local restaurants and retailers. You could also use the time to touch base with those who remain isolated and vulnerable. Well, whatever you do, have a grand time. But be safe and wear a mask. Enjoy, and see you soon. …

Sanofi (SNY) is considering cutting hundreds of jobs and will discuss potential steps with staff representatives over the coming days, Reuters reports. The reorganization could involve employees in several European countries and possibly others outside the region, as well as all the divisions of Sanofi except the vaccines and rare diseases unit Genzyme. Around 1,000 jobs in France are at risk, and the cuts are expected to take place over a three-year period.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy